BioTech, Free Full-Text

(1) Background: The COVID-19 pandemic left many intriguing mysteries. Retrospective vulnerability trends tie as strongly to odd demographics as to exposure profiles, genetics, health, or prior medical history. This article documents the importance of nasal microbiome profiles in distinguishing infection rate trends among differentially affected subgroups. (2) Hypothesis: From a detailed literature survey, microbiome profiling experiments, bioinformatics, and molecular simulations, we propose that specific commensal bacterial species in the Pseudomonadales genus confer protection against SARS-CoV-2 infections by expressing proteases that may interfere with the proteolytic priming of the Spike protein. (3) Evidence: Various reports have found elevated Moraxella fractions in the nasal microbiomes of subpopulations with higher resistance to COVID-19 (e.g., adolescents, COVID-19-resistant children, people with strong dietary diversity, and omnivorous canines) and less abundant ones in vulnerable subsets (the elderly, people with narrower diets, carnivorous cats and foxes), along with bioinformatic evidence that Moraxella bacteria express proteases with notable homology to human TMPRSS2. Simulations suggest that these proteases may proteolyze the SARS-CoV-2 spike protein in a manner that interferes with TMPRSS2 priming.

Biopharma Daily Stock Updates - 04/29/22

Patterns of Prejudice on X: FREE TO READ: Troy Duster's (@NYU_LS

Buy From Alchemy To Ipo: The Business Of Biotechnology on ✓ FREE SHIPPING on qualified orders

From Alchemy To Ipo: The Business Of Biotechnology

Plant Biotechnology Journal: Vol 20, No 1

Biotech companies Jun 14th 2003 Edition

Cell-free Production: System Development

PDF] Optimization of glutaminase-free L-asparaginase production

CORE and PubMed collaborate for further full text dissemination

Isothermal, in vitro amplification of nucleic acids by a

BIOTECH: Value-Based Pricing In Biotechnology